Format

Send to

Choose Destination
Arch Neurol. 2001 Nov;58(11):1793-8.

Feasibility of gene therapy for late neuronal ceroid lipofuscinosis.

Author information

1
Institute of Genetic Medicine and Belfer Gene Therapy Core Facility, Weill Medical College of Cornell University, 515 E 71st St, Suite 1000, New York, NY 10021, USA.

Abstract

Late infantile neuronal ceroid lipofuscinosis is a progressive childhood neurodegenerative disorder characterized by intracellular accumulation of autofluorescent material resembling lipofuscin in neuronal cells. This report summarizes the new therapies under consideration for late infantile neuronal ceroid lipofuscinosis, with a focus on strategies for in vivo gene therapy for the retinal and central nervous system manifestations of the disease.

PMID:
11708986
DOI:
10.1001/archneur.58.11.1793
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center